The emergency use authorization of a second COVID-19 vaccine today means that millions more people can be immunized against this virus in the weeks to come.
The emergency use authorization of a second COVID-19 vaccine today means that millions more people can be immunized against this virus in the weeks to come.
AABB and the Infectious Diseases Society of America issued today a resource document outlining considerations for clinicians on the use of COVID-19 convalescent plasma under the Emergency Use Authorization granted by the Food and Drug Administration.
“The first Emergency Use Authorization of a vaccine against the novel coronavirus in the United States offers a promising opportunity to reverse the trajectory of the COVID-19 pandemic." Read Full Statement
Congressional Rep. Mike Doyle (D-PA) and Rep. Drew Ferguson (R-GA) today introduced The Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act
In a Dec. 7 letter to National Institutes of Health Director Francis Collins, MD, PhD, on the agency’s Strategic Plan for COVID-19 Research, IDSA President Barbara Alexander, MD, MHS, FIDSA, calls for cross-cutting strategies
The Infectious Diseases Society of America (IDSA), the nation’s leading infectious diseases professional society, recognizes the distinguished physicians and scientists from the United States and around the world who were elected this year to be Fellows of IDSA.
In the face of new challenges to the access to testing, prevention, care and treatment necessary to stop HIV transmissions, infections, illnesses and deaths at home and globally, the theme of this year’s World AIDS Day: Ending the HIV/AIDS Epidemic: Resilience and Impact must drive the efforts ahead.
Among the nine exceptional individuals being recognized by the Infectious Diseases Society of America, James D. Cherry, M.D., FIDSA, has been honored with this year’s Alexander Fleming Award for lifetime achievement. IDSA is pleased to acknowledge the following individuals for excellence in the field of infectious diseases with its annual Society Awards:
A new evidence-based clinical practice guideline for the prevention, diagnosis and treatment of the worldwide disease caused by Babesia parasites has been published in Clinical Infectious Diseases. Providing current standards of diagnosis and management of human babesiosis, the 2020 Guideline on Diagnosis and Management of Babesiosis was developed by a multidisciplinary panel convened by IDSA.
New evidence-based clinical practice guidelines for the prevention, diagnosis, and treatment of Lyme disease have been developed by a multidisciplinary panel led by the IDSA, the American Academy of Neurology, and the American College of Rheumatology. Representatives from an additional 12 medical specialties and patients also served on the panel.
The four principles established by CDC’s Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine set a positive course for mitigating and containing the impacts of the pandemic.
Barbara D. Alexander, M.D., MHS, FIDSA – President, Infectious Diseases Society of America on today’s Pfizer/BioNTech application for Emergency Use Authorization of its COVID-19 vaccine candidate